These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33525304)

  • 41. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis.
    Vitti P; Rago T; Mazzeo S; Brogioni S; Lampis M; De Liperi A; Bartolozzi C; Pinchera A; Martino E
    J Endocrinol Invest; 1995 Dec; 18(11):857-61. PubMed ID: 8778158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Graves' disease associated with alopecia areata developing after Hashimoto's thyroiditis.
    Aşık M; Binnetoğlu E; Şen H; Tekeli Z; Uysal F; Ukinç K
    J Nippon Med Sch; 2013; 80(6):467-9. PubMed ID: 24419720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves' disease.
    Tada H; Mizuta I; Takano T; Tatsumi KI; Izumi Y; Hidaka Y; Amino N
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):403-8. PubMed ID: 12641621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis.
    Wenzel BE; Chow A; Baur R; Schleusener H; Wall JR
    Thyroid; 1998 Nov; 8(11):1019-22. PubMed ID: 9848716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three patients who spontaneously developed persistent hypothyroidism during or following treatment with antithyroid drugs for Graves' hyperthyroidism.
    Shigemasa C; Mitani Y; Taniguchi S; Adachi T; Ueta Y; Urabe K; Miyazaki S; Tanaka T; Yoshida A; Mashiba H
    Arch Intern Med; 1990 May; 150(5):1105-9. PubMed ID: 1691909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
    Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
    Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I; Bokk A
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Four patients with hypothyroid Graves' disease.
    Starrenburg-Razenberg AJ; Castro Cabezas M; Gan IM; Njo TL; Rietveld AP; Elte JW
    Neth J Med; 2010 Apr; 68(4):178-80. PubMed ID: 20421660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases.
    Sawicka B; Bossowski A; Szalecki M; Wysoka J; Koput A; Zelazowska-Rutkowska B; Tobolczyk J; Rogowski F; Łuba M
    J Pediatr Endocrinol Metab; 2010 Apr; 23(4):345-54. PubMed ID: 20583539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary immune thrombocytopenia responding to antithyroid treatment in a patient with Graves' disease.
    Gill H; Hwang YY; Tse E
    Ann Hematol; 2011 Feb; 90(2):223-4. PubMed ID: 20467745
    [No Abstract]   [Full Text] [Related]  

  • 52. Age-related changes of thyroid function and immunologic abnormalities in patients with hyperthyroidism due to Graves' disease.
    Aizawa T; Ishihara M; Hashizume K; Takasu N; Yamada T
    J Am Geriatr Soc; 1989 Oct; 37(10):944-8. PubMed ID: 2794317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
    J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship among thyrotropin (TSH), thyroid stimulating immunoglobulins, and results of triiodothyronine (T3) suppression test in patients with Graves' disease.
    Horimoto M; Nishikawa M; Uno C; Yoshikawa N; Taniguchi N; Inada M
    Endocrinol Jpn; 1988 Dec; 35(6):841-8. PubMed ID: 2471633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
    Wall JR; Chartier B
    J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic recurrent stress due to panic disorder does not precipitate Graves' disease.
    Chiovato L; Marinò M; Perugi G; Fiore E; Montanelli L; Lapi P; Cavaliere R; Ciampi M; Patronelli A; Placidi G; Placidi GF; Cassano GB; Pinchera A
    J Endocrinol Invest; 1998 Dec; 21(11):758-64. PubMed ID: 9972676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis.
    Hymes K; Blum M; Lackner H; Karpatkin S
    Ann Intern Med; 1981 Jan; 94(1):27-30. PubMed ID: 6893793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.
    Žarković M; Wiersinga W; Perros P; Bartalena L; Donati S; Okosieme O; Morris D; Fichter N; Lareida J; Daumerie C; Burlacu MC; Kahaly GJ; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
    J Endocrinol Invest; 2021 Feb; 44(2):371-378. PubMed ID: 32524368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.